596817-50-4 Usage
Uses
Used in Pharmaceutical Industry:
[1-(6-Chloro-pyrimidin-4-yl)-piperidin-4-yl]-carbamic acid tert-butyl ester, 98+% C14H21ClN4O2, MW: 312.8 is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique chemical structure, including the chloro and pyrimidin-4-yl groups, may contribute to the development of new therapeutic agents with specific biological activities.
Used in Chemical Synthesis:
[1-(6-Chloro-pyrimidin-4-yl)-piperidin-4-yl]-carbamic acid tert-butyl ester, 98+% C14H21ClN4O2, MW: 312.8 is used as a precursor in the synthesis of other complex organic compounds. The tert-butyl ester group allows for selective reactions and transformations, making it a valuable building block in the creation of a wide range of chemical products.
Used in Laboratory Research:
[1-(6-Chloro-pyrimidin-4-yl)-piperidin-4-yl]-carbamic acid tert-butyl ester, 98+% C14H21ClN4O2, MW: 312.8 is used as a research compound in various scientific studies. Its unique properties and potential applications make it an interesting subject for investigation, particularly in the fields of organic chemistry, medicinal chemistry, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 596817-50-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,6,8,1 and 7 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 596817-50:
(8*5)+(7*9)+(6*6)+(5*8)+(4*1)+(3*7)+(2*5)+(1*0)=214
214 % 10 = 4
So 596817-50-4 is a valid CAS Registry Number.
596817-50-4Relevant academic research and scientific papers
Mule, Siva Nagi Reddy,Nurbhasha, Sharmila,Kolla,Jadav, Surender Singh,Jayaprakash, Venkatesan,Bhavanam, Lourdu Rani,Bollikolla, Hari Babu
, p. 2534 - 2546 (2016)
Novel 4, 6-disubstituted pyrimidine derivatives (5–16) were synthesized in four steps starting from 2,4-dichloropyrimidine and screened for their cytotoxicity using brine shrimp (Artemia Salina) lethality bioassay. The compounds such as 6, 11, 14 and 15 w
PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF SPHINGOSINE KINASE
-
Page/Page column 114, (2012/06/15)
The present invention relates to compounds that are useful as inhibitors of the activity of one or more isoforms of sphingosine kinase. Particularly, although not exclusively, the present invention also relates to pharmaceutical compositions comprising th
NEW COMPOUNDS
-
Page/Page column 33; 34, (2008/06/13)
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
